• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND SARS-COV-2 IGG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND SARS-COV-2 IGG Back to Search Results
Catalog Number 06R90-22
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/24/2021
Event Type  malfunction  
Event Description
The customer observed false negative alinity i sars-cov-2 igg results for several patients since using a new sars-cov-2 igg reagent lot 33057ud00.The customer reran some patient samples that previously generated a positive result, however when tested using the new reagent lot are generating a negative result.There is no specific patient data or patient information provided by the customer.There was no impact to patient management reported.
 
Manufacturer Narrative
This report is being filed on an international product, list number 06r90-22 (sars-cov-2 igg) that has a similar product distributed in the us, list number 06r90-20 /-30 (sars-cov-2 igg), (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation for falsely negative alinity i sars-cov-2 igg results included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not performed as returns were not available.The ticket search determined normal complaint activity for the likely cause lot.Trending review determined no trends identified for the product for the issue.Clinical sensitivity and specificity testing was completed with an in-house retained kit of the complaint lot 33057ud00.All specifications were met indicating the lots are performing acceptably.Device history record was reviewed and did not identify any non-conformances or deviations.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or product deficiency for alinity i sars-cov-2 igg reagent lot 33057ud00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SARS-COV-2 IGG
Type of Device
SARS-COV-2 IGG
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key12586528
MDR Text Key283477413
Report Number3008344661-2021-00182
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/26/2022
Device Catalogue Number06R90-22
Device Lot Number33057UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/14/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
-
-